ADVERTISEMENT
Search

Ilisa Bernstein

CEO Blog: Ilisa Bernstein, PharmD, JD, FAPhA

Ilisa Bernstein, PharmD, JD, FAPhA, is Interim CEO at the American Pharmacists Association (APhA). She is responsible for leading the development and implementation of APhA’s strategies related to pharmacy practice and professional affairs, advocacy, and government affairs.

Read more about Ilisa

Workplace conditions and well-being

Workplace conditions and well-being

We hear you! Your pharmacy workplace is stressed and stretched. You have rapidly growing concerns for patient safety. Still, you are there—every day—to care for your patients despite conditions that seem to be working against you.

The federal government needs drug price solutions. We’ve got their back.

The federal government needs drug price solutions. We’ve got their back.

Earlier this month, HHS was working on an aggressive deadline. President Joe Biden had given them 45 days to develop a comprehensive plan to lower drug prices, and the clock was ticking. HHS asked stakeholders across the spectrum to provide input during a special roundtable discussion. Guess who they called from pharmacy?

Calling balls and strikes on PBMs—and the other players, too

Calling balls and strikes on PBMs—and the other players, too

It should be abundantly clear that APhA has several bones to pick with big pharmacy benefit managers (PBMs). These PBMs, operating under the guise of altruism, paint themselves as saints who work to lower prescription drug prices for the masses. Instead, they actively game the system by knocking out pharmacy competitors, reducing patient access to medicines and pharmacist services, and ripping off patients, employers, and taxpayers.

RSS